EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review

Jola Bytyci, Yuxin Ying iD, Lennard Y W Lee

Immunity, Inflammation and Disease · 2024-04 · 12 (4)

DOI: 10.1002/iid3.1259 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 25.04.2024. Verfasst von Jola Bytyci und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Medical School, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Breakthrough Infections, COVID-19, COVID-19 Vaccines, Immunocompromised Host. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Immunocompromised individuals have been shown to mount a reduced response to vaccination, resulting in reduced vaccine effectiveness in this cohort. Therefore, in the postvaccination era, immunocompromised individuals remain at high risk of breakthrough infection and COVID‐19 related hospitalization and death, which persist despite vaccination efforts. There has been a marked paucity of systematic reviews evaluating existing data describing the clinical measures of efficacy of COVID‐19 vaccination, specifically in immunocompromised populations. In particular, there is a scarcity of comprehensive evaluations exploring breakthrough infections and severe COVID‐19 in this patient population.

Methods

To address this gap, we conducted a systematic review which aimed to provide a summary of current clinical evidence of the effectiveness of COVID‐19 vaccination in the immunocompromised population. Using PRISMA guidelines, we conducted a literature search on PubMed and the Cochrane database published between January 1, 2021 to September 1, 2022.

Results

Our findings demonstrated that despite vaccination, immunocompromised patients remained at high risk of new breakthrough COVID‐19 infection and severe COVID‐19 outcomes compared to the general population. We found increased average relative risk (RR) of breakthrough infections in the immunocompromised population, including patients with cancer (RR = 1.4), HIV (RR = 1.92), chronic kidney disease (RR = 2.26), immunodeficiency (RR = 2.55), and organ transplant recipients (RR = 6.94). These patients are also at greater risk for hospitalizations and death following COVID‐19 breakthrough infection. We found that the RR of hospitalization and death in Cancer patients was 1.08 and 2.82, respectively.

Conclusion

This demonstrated that vaccination does not offer an adequate level of protection in these groups, necessitating further measures such as Evusheld and further boosters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breakthrough InfectionsCOVID-19COVID-19 VaccinesImmunocompromised HostHumansHospitalizationNeoplasmsRisk FactorsVaccinationVaccine Efficacy

Stichwörter der Autor:innen

SARS‐CoV‐2cancersevere COVID‐19 outcomesvaccine effectiveness

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Oxford Medical School, University of Oxford, Oxford, UK.
  • Institute of Cancer and Genomic 22 Sciences, University of Birmingham, Birmingham, UK.
  • Department of Oncology, University of Oxford, Oxford, United Kingdom.

ORCID-Profile: Yuxin Ying

Zitieren

APA

Bytyci, J., Ying, Y., & Lee, L. Y. W. (2024). Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review. Immunity, Inflammation and Disease, 12(4). https://doi.org/10.1002/iid3.1259

Vancouver

Bytyci J, Ying Y, Lee LYW. Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review. Immunity, Inflammation and Disease. 2024;12(4). doi:10.1002/iid3.1259

BibTeX
@article{Bytyci2024,
  author = {Bytyci, Jola and Ying, Yuxin and Lee, Lennard Y W},
  title = {Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  volume = {12},
  number = {4},
  doi = {10.1002/iid3.1259}
}
Kostenlos starten →